A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus

A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus

A critical aspect of the treatment of most patients with type 2 diabetes mellitus (T2DM) is the initiation (and subsequent intensification) of insulin therapy when lifestyle interventions and oral anti-hyperglycaemic drugs fail to maintain or improve glycaemic control. There are several insulin trea...

Full description

Bibliographic Details
Main Authors:	Marina V. Shestakova, Svetlana V. Elizarova, Abdul Jabbar
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2016-07-01
Series:	Сахарный диабет
Subjects:	type 2 diabetes mellitus humalog insulin lispro premixed insulin analog initiation intensification glycated hemoglobin efficacy safety
Online Access:	https://www.dia-endojournals.ru/jour/article/view/7595

Similar Items

Efficacy and safety of ultra-rapid lispro insulin in managing type-1 and type-2 diabetes: A systematic review and meta-analysis
by: Deep Dutta, et al.
Published: (2023-01-01)

Meeting of the expert committee on the use of pre-mixed insulin preparation Humalog Mix 50 in type 2 diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2013-12-01)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
by: Elena V. Buryukova, et al.
Published: (2017-12-01)

Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature
by: Ajay Kumar
Published: (2016-01-01)

High-mix insulins
by: Sanjay Kalra, et al.
Published: (2015-01-01)

Case of subcutaneous insulin resistance syndrome treated with ultra‐rapid insulin lispro
by: Takahiro Ishii, et al.
Published: (2022-03-01)

Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea
by: Kim HS, et al.
Published: (2022-05-01)

Valutazione clinica e metabolica dell’impiego dell’insulina Lispro in pazienti con diabete mellito scompensato
by: Antonio Uneddu, et al.
Published: (2005-12-01)

Comparison of Premixed Human Insulin 30/70 to Biphasic Aspart 30 in Well-Controlled Patients with Type 2 Diabetes Using Continuous Glucose Monitoring
by: Charalampos Margaritidis, et al.
Published: (2021-05-01)

Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis
by: Karla F. S. Melo, et al.
Published: (2019-01-01)

South Asian Consensus Guideline: Use of insulin in diabetes during Ramadan
by: Md Faruque Pathan, et al.
Published: (2012-01-01)

The effect of insulin analogs in people with type 1 diabetes at increased risk of severe hypoglycemia
by: Sofie Broeng-Mikkelgaard, et al.
Published: (2023-11-01)

Choice of insulin in type 2 diabetes: A Southeast Asian perspective
by: Sanjay Kalra, et al.
Published: (2017-01-01)

Intensifying existing premix therapy (BIAsp 30) with BIAsp 50 and BIAsp 70: A consensus statement
by: Miguel Brito, et al.
Published: (2011-01-01)

Análogos de insulina Insulin analogues
by: Manuel E. Licea Puig
Published: (2006-12-01)

The use of long-acting insulin degludec in adult patients with type 2 diabetes mellitus in real clinical practice in Russia
by: G. R. Galstyan
Published: (2023-02-01)

Investigating the level of Hba1c and insulin level in β-thalassemia patients
by: Husnan Mujiburrahman, et al.
Published: (2023-12-01)

Proteomic Changes to the Updated Discovery of Engineered Insulin and Its Analogs: Pros and Cons
by: Naeema Hanif, et al.
Published: (2022-02-01)

Efficacy and pathogenetic justification for the use of vildagliptin in patients with type 2 diabetes mellitus
by: V.I. Pankiv
Published: (2019-10-01)

Which people with diabetes are treated with a disposable, half‐unit insulin pen? A real‐world, retrospective, database study in Spain
by: F. Javier Ampudia‐Blasco, et al.
Published: (2023-11-01)

Ultra‐Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog® in Japanese patients with type 1 diabetes
by: Masanari Shiramoto, et al.
Published: (2020-05-01)

Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China
by: Guangxu Liu, et al.
Published: (2018-10-01)

Efficacy and Safety of Intramuscular Insulin Lispro vs. Continuous Intravenous Regular Insulin for the Treatment of Dogs With Diabetic Ketoacidosis
by: Eleonora Malerba, et al.
Published: (2020-10-01)

Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
by: Elena Efimovna Petryaykina, et al.
Published: (2009-09-01)

A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus
by: Jiyun Park, et al.
Published: (2022-11-01)

Estimated Glycated albumin' levels early in pregnancy could detect women at risk to develop gestational diabetes mellitus
by: Amr Sharafeldeen *, et al.
Published: (2023-07-01)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
by: Ivan Ivanovich Dedov, et al.
Published: (2014-12-01)

Efficacy of insulin lispro in improving glycemic control in gestational diabetes
by: M C Deepaklal, et al.
Published: (2014-01-01)

Glycemic control in patients with diabetes mellitus on hemodialysis
by: K G Lobanova, et al.
Published: (2019-10-01)

Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials
by: Rodrigo Ribeiro e Silva, et al.
Published: (2023-06-01)

New Basal Insulin Toujeo Solostar: Increased Therapeutic Potential for the Control of Dysglycaemia in Diabetes Mellitus
by: V.V. Poltorak
Published: (2016-05-01)

Assessment of the serum level of melatonin and its correlation with insulin, insulin resistance, and glycated hemoglobin in Iraqi patients with polycystic ovarian syndrome
by: Ahmed Abduljabbar Hameed, et al.
Published: (2019-01-01)

Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis
by: E. V. Biryukova, et al.
Published: (2017-11-01)

Protocol to Assess the Biological Activity of Insulin Glargine, Insulin Lispro, and Insulin Aspart In Vitro
by: Mamatha Garige, et al.
Published: (2023-03-01)

Effectiveness of Insulin Analogs Compared with Human Insulins in Pregnant Women with Diabetes Mellitus: Systematic Review and Meta-analysis
by: Leyna Leite Santos, et al.

Flexibility in insulin prescription
by: Sanjay Kalra, et al.
Published: (2016-01-01)

High concentration insulin
by: Sanjay Kalra
Published: (2018-01-01)

Treatment of Type 2 Diabetes with Biphasic Insulin Analogues
by: Ali A. Rizvi
Published: (2016-10-01)

GESTATIONAL DIABETES MELLITUS: GENETIC MARKERS OF INSULIN RESISTANCE, DIAGNOSTIC CRITERIA AND MANAGEMENT TACTICS
by: Nikonova L. V., et al.
Published: (2020-12-01)

Efficacy and Safety of Insulin Degludec/Insulin Aspart Compared with a Conventional Premixed Insulin or Basal Insulin: A Meta-Analysis
by: Shinje Moon, et al.
Published: (2021-09-01)